Back to the future with noninvasive biomarkers of liver fibrosis

Hepatology

Volumn 49, Issue 1, 2009, Pages 9-11

  Guha, Indra Neil ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; EDITORIAL; HEPATIC VENOUS PRESSURE GRADIENT; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER FIBROSIS; MORTALITY; NON INVASIVE PROCEDURE; OVERALL SURVIVAL; PRESSURE GRADIENT; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; ALCOHOL LIVER DISEASE; COHORT ANALYSIS; NOTE;

BIOLOGICAL MARKERS; COHORT STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; PROGNOSIS;

EID: 58949088367     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22735     Document Type: Editorial

References (15)

1. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. HEPATOLOGY 1996;23:1334-1340.
2. Neal K, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: A prospective study. Gut 2007;56:1098-1104.
3. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991;86:210-216.
4. Marbet UA, Bianchi L, Meury U, Stalder GA. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987;4:364-372.
5. Naveau S, Gaudée G, Asnacios A, Agostini H, Abella A, Barri-Ova N, et al. Diagnostic and prognostic values of non-invasive biomarkers of fibrosis in patients with alcoholic liver disease. HEPATOLOGY 2009; doi: 10.1002/hep.22576.
6. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006;52:1887-1896.
7. Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44: 462-474.
8. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review. HEPATOLOGY 2007;46:912-921.
9. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49:1-6.
10. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978;299:926-930.
11. Blasco A, Forns X, Carrion JA, Garcia-Pagan JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. HEPATOLOGY 2006;43: 492-499.
12. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791-1798.
13. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007;45:1290-1297.
14. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. HEPATOLOGY 2008;47:380-384.
15. Cobbold JF, Taylor-Robinson SD. Transient elastography in acute hepatitis: All that's stiff is not fibrosis. HEPATOLOGY 2008;47:370-372.